FR3110582B1 - Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. - Google Patents

Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. Download PDF

Info

Publication number
FR3110582B1
FR3110582B1 FR2005382A FR2005382A FR3110582B1 FR 3110582 B1 FR3110582 B1 FR 3110582B1 FR 2005382 A FR2005382 A FR 2005382A FR 2005382 A FR2005382 A FR 2005382A FR 3110582 B1 FR3110582 B1 FR 3110582B1
Authority
FR
France
Prior art keywords
biomaterial
elastomeric matrix
sulphated polysaccharide
polysaccharide
reconstruction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2005382A
Other languages
English (en)
Other versions
FR3110582A1 (fr
Inventor
Didier Lutomski
Géraldine Rohman
Sylvie Changotade
Karim Senni
Carole Chakar
Wassim Manhal
Ronald Younes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite St Joseph De Beyrouth Lb
Centre National de la Recherche Scientifique CNRS
Universite Sorbonne Paris Nord
Universite Paris Cite
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Sorbonne Paris Nord
Universite de Paris
Univ St Joseph De Beyrouth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Sorbonne Paris Nord, Universite de Paris, Univ St Joseph De Beyrouth filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR2005382A priority Critical patent/FR3110582B1/fr
Priority to JP2022571177A priority patent/JP7802692B2/ja
Priority to EP21726418.3A priority patent/EP4153651A1/fr
Priority to PCT/EP2021/063472 priority patent/WO2021234088A1/fr
Priority to US17/997,433 priority patent/US20230263937A1/en
Priority to CN202080101135.0A priority patent/CN115803356B/zh
Publication of FR3110582A1 publication Critical patent/FR3110582A1/fr
Application granted granted Critical
Publication of FR3110582B1 publication Critical patent/FR3110582B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/16—Catalysts
    • C08G18/22—Catalysts containing metal compounds
    • C08G18/24—Catalysts containing metal compounds of tin
    • C08G18/244—Catalysts containing metal compounds of tin tin salts of carboxylic acids
    • C08G18/246—Catalysts containing metal compounds of tin tin salts of carboxylic acids containing also tin-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/4269—Lactones
    • C08G18/4277—Caprolactone and/or substituted caprolactone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)

Abstract

« Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. » La présente invention concerne un biomatériau comprenant au moins une matrice élastomère et un polysaccharide, et ses utilisations dans le renforcement, la reconstruction et/ou du comblement des défauts tissulaires, de préférence le renforcement, la reconstruction et/ou du comblement des défauts des tissus mous et/ou les tissus épithéliaux, de préférence la réparation de la peau et/ou des muqueuses.
FR2005382A 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. Active FR3110582B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR2005382A FR3110582B1 (fr) 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.
JP2022571177A JP7802692B2 (ja) 2020-05-20 2021-05-20 少なくとも１つのエラストマーマトリックスおよび非硫酸化多糖を含む生体材料およびその使用
EP21726418.3A EP4153651A1 (fr) 2020-05-20 2021-05-20 Biomateriau comprenant au moins une matrice elastomere et un polysaccharide non sulfate et ses utilisations
PCT/EP2021/063472 WO2021234088A1 (fr) 2020-05-20 2021-05-20 Biomateriau comprenant au moins une matrice elastomere et un polysaccharide non sulfate et ses utilisations
US17/997,433 US20230263937A1 (en) 2020-05-20 2021-05-20 Biomaterial comprising at least one elastomeric matrix and a non-sulfated polysaccharide and uses thereof
CN202080101135.0A CN115803356B (zh) 2020-05-20 2021-05-20 包括至少一种弹性体基质和非硫酸化多糖的生物材料及其用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2005382 2020-05-20
FR2005382A FR3110582B1 (fr) 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.

Publications (2)

Publication Number Publication Date
FR3110582A1 FR3110582A1 (fr) 2021-11-26
FR3110582B1 true FR3110582B1 (fr) 2023-04-14

Family

ID=72178756

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2005382A Active FR3110582B1 (fr) 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.

Country Status (6)

Country Link
US (1) US20230263937A1 (fr)
EP (1) EP4153651A1 (fr)
JP (1) JP7802692B2 (fr)
CN (1) CN115803356B (fr)
FR (1) FR3110582B1 (fr)
WO (1) WO2021234088A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130295081A1 (en) * 2008-10-30 2013-11-07 Vanderbilt University Polyurethane Composite for Wound Healing and Methods Thereof
US9050176B2 (en) * 2009-04-03 2015-06-09 Biomerix Corporation At least partially resorbable reticulated elastomeric matrix elements and methods of making same
WO2011075183A1 (fr) * 2009-12-15 2011-06-23 Vanderbilt University Composites tissu-polyuréthane injectables/se formant in situ et procédés de préparation associés
US10772992B2 (en) * 2016-02-17 2020-09-15 The Governing Council Of The University Of Toronto Soft tissue filler
CN108034225B (zh) * 2017-12-25 2020-07-10 武汉市工程科学技术研究院 一种制备壳聚糖/热塑性聚氨酯弹性体复合材料的方法

Also Published As

Publication number Publication date
JP2023526504A (ja) 2023-06-21
WO2021234088A1 (fr) 2021-11-25
FR3110582A1 (fr) 2021-11-26
EP4153651A1 (fr) 2023-03-29
JP7802692B2 (ja) 2026-01-20
US20230263937A1 (en) 2023-08-24
CN115803356A (zh) 2023-03-14
CN115803356B (zh) 2026-03-27

Similar Documents

Publication Publication Date Title
CR8108A (es) Tratamiento con anticuerpos anti-vegf
ES2186389T3 (es) Sistema de acoplamiento (carga blanca/elastomero dienico) a base de alcoxisilano polisulfurado, ditiofosfato de cinc y derivado guanidinico.
WO2007064881A3 (fr) Materiaux en cellulose microbienne implantables pour diverses applications medicales
MXPA05001602A (es) Dispositivo de colageno y metodo para preparar el mismo.
UA130422C2 (uk) Варіант та ізоформа антитіла зі зниженою біологічною активністю
TNSN07401A1 (fr) Anticorps diriges contre le peptide amyloide-beta, et methodes pour leurs utilisations
BRPI0921999B8 (pt) uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
PE20050712A1 (es) Anticuerpos rg1
BRPI0500052A (pt) Método / sistema para acabar um poço com junta de transição selada de poço ramal
PE20070123A1 (es) Composicion inmunogenica
BRPI0720183A2 (pt) Produto para tratamento bucal, método de remineralização e/ou branqueamento, produto que compreende uma primeira composição em combinação com uma segunda composição e uso
Mavrilas et al. Dynamic mechanical characteristics of intact and structurally modified bovine pericardial tissues
IL176419A0 (en) An implant for occluding a body passage
Shayan et al. Re: The'keystone concept': time for some science.
FR3110582B1 (fr) Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.
BR112012010252A2 (pt) variantes de glicosilação de anticorpo
Vidal et al. Role of proteoglycans on the biochemical and biomechanical properties of dentin organic matrix
BR112021019950A2 (pt) Métodos de esgotamento de agentes causadores de doenças por meio de anticorpo de fagocitose alvejada
MX2022010217A (es) Composicion farmaceutica que contiene anticuerpo anti-il-4r y uso de la misma.
WO2022006492A3 (fr) Sialidases recombinantes à sensibilité à la protéase réduite, protéines de fusion de sialidase et leurs méthodes d'utilisation
BR112022010831A2 (pt) Composições estéticas de alto peso molecular
BR112012018970A2 (pt) método para selagem aprimorada com fibrina
MX2023001937A (es) Anticuerpos monoclonales, composiciones y métodos para detectar el factor d del complemento.
Hahn et al. Glycosaminoglycan composition of the vocal fold lamina propria in relation to function
BR112022010167A2 (pt) Proteína imunogênica contra infecção gonocócica

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20211126

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

CD Change of name or company name

Owner name: UNIVERSITE ST-JOSEPH DE BEYROUTH, LB

Effective date: 20230330

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR

Effective date: 20230330

Owner name: UNIV PARIS XIII PARIS-NORD VILLETANEUSE, FR

Effective date: 20230330

Owner name: UNIVERSITE PARIS CITE, FR

Effective date: 20230330

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6